1. Home
  2. RCUS vs MRC Comparison

RCUS vs MRC Comparison

Compare RCUS & MRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • MRC
  • Stock Information
  • Founded
  • RCUS 2015
  • MRC 1921
  • Country
  • RCUS United States
  • MRC United States
  • Employees
  • RCUS N/A
  • MRC N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • MRC Industrial Machinery/Components
  • Sector
  • RCUS Health Care
  • MRC Industrials
  • Exchange
  • RCUS Nasdaq
  • MRC Nasdaq
  • Market Cap
  • RCUS 1.4B
  • MRC 1.2B
  • IPO Year
  • RCUS 2018
  • MRC 2012
  • Fundamental
  • Price
  • RCUS $16.68
  • MRC $12.40
  • Analyst Decision
  • RCUS Strong Buy
  • MRC Strong Buy
  • Analyst Count
  • RCUS 10
  • MRC 3
  • Target Price
  • RCUS $35.88
  • MRC $15.67
  • AVG Volume (30 Days)
  • RCUS 576.8K
  • MRC 414.6K
  • Earning Date
  • RCUS 11-05-2024
  • MRC 11-05-2024
  • Dividend Yield
  • RCUS N/A
  • MRC N/A
  • EPS Growth
  • RCUS N/A
  • MRC 1.10
  • EPS
  • RCUS N/A
  • MRC 0.94
  • Revenue
  • RCUS $247,000,000.00
  • MRC $3,294,000,000.00
  • Revenue This Year
  • RCUS $132.82
  • MRC N/A
  • Revenue Next Year
  • RCUS N/A
  • MRC $4.34
  • P/E Ratio
  • RCUS N/A
  • MRC $13.32
  • Revenue Growth
  • RCUS 104.13
  • MRC N/A
  • 52 Week Low
  • RCUS $12.95
  • MRC $9.47
  • 52 Week High
  • RCUS $20.60
  • MRC $14.91
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 51.22
  • MRC 48.68
  • Support Level
  • RCUS $15.30
  • MRC $11.24
  • Resistance Level
  • RCUS $18.28
  • MRC $13.28
  • Average True Range (ATR)
  • RCUS 0.85
  • MRC 0.33
  • MACD
  • RCUS -0.04
  • MRC 0.01
  • Stochastic Oscillator
  • RCUS 48.57
  • MRC 56.86

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About MRC MRC Global Inc.

MRC Global Inc distributes pipes, valves, fittings, and related products and services to the energy industry. Products are often used in the construction, maintenance, repair, and overhaul of equipment used in extreme operating conditions. In these conditions and other environments, MRC's valve products give the customer the ability to control the direction, velocity, and pressure of fluids and gases within transmission networks. In addition, other products can be used to regulate flow and on/off service. MRC's other products, which include pipe, steel fitting, and tubular goods, are used across all of the industries in which the company operates. Specialized services are delivered alongside this array of products to enhance the client relationship.

Share on Social Networks: